Navigation Links
At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed)

y Rat Neurons by a GABA-Independent Pathway in presentation P-192. About Neurochem

Neurochem Inc. is focused on the development and commercialization of innovative therapeutics to address critical unmet medical needs. Eprodisate (KIACTA(TM)) is currently being developed for the treatment of Amyloid A (AA) amyloidosis, and is under regulatory review for marketing approval by the United States Food and Drug Administration, European Medicines Agency and Swissmedic. Tramiprosate (ALZHEMED(TM)), for the treatment of Alzheimer's disease, has completed a Phase III clinical trial in North America and is currently in a Phase III clinical trial in Europe, while tramiprosate (CEREBRIL(TM)), for the prevention of Hemorrhagic Stroke caused by Cerebral Amyloid Angiopathy, has completed a Phase IIa clinical trial.

To Contact Neurochem

For additional information on Neurochem and its drug development programs, please call the North American toll-free number 1 877 680-4500 or visit our Web Site at: www.neurochem.com.

This news release contains forward-looking statements regarding tramiprosate (ALZHEMED(TM)) as well as regarding continuing and further development efforts. These statements are based on the current analysis and expectations of management. Drug development necessarily involves numerous risks and uncertainties, which could cause actual results to differ materially from this current analysis and these expectations. Analysis regarding the results of clinical trials may not provide definitive results regarding safety, tolerability or therapeutic benefits. Even if all the endpoints sought in the clinical trials were met (which is not certain), there is no certainty that regulators would ultimately approve tramiprosate (ALZHEMED(TM)) for sale to the public. Risks and uncertainties may include: failure to demonstrate the safety, tolerability and efficacy of our product, that ac
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
2. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
3. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
6. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
7. Clinical Update - Debio 9902 (ZT-1) for Alzheimers Disease
8. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
9. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
10. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
11. Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimers Drug
Post Your Comments:
(Date:11/26/2014)...  Aethlon Medical, Inc. (OTCQB:AEMD), announced today that it ... $3.3 million at a price of $0.30 per unit. ... investor. Each unit consists of one common share and ... Each whole warrant entitles the holder to acquire one ... period of five years from closing.  ...
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Genomic Health, ... Kim Popovits , Chairman, Chief Executive Officer and President, ... Jaffray Healthcare Conference at The New York Palace Hotel ... December 3 at 11:30 am Eastern Time (ET). ... of the conference call, go to the  Investor Relations ...
(Date:11/26/2014)... , Nov. 26, 2014  Avanir Pharmaceuticals, ... the U.S. Food and Drug Administration (FDA) has ... Drug Application (NDA) for AVP-825. AVP-825 is an ... powder delivered intranasally utilizing a novel Breath Powered ... Response letter, and consistent with the preliminary feedback ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
(Date:11/28/2014)... NEW ALBANY, IN (PRWEB) November 28, 2014 ... of Americans were already preparing for the Christmas shopping season. ... the best deals on Black Friday, the biggest retail shopping ... the latest gadget or electronic device, New Albany dentist ... gift options that can improve oral health and literally brighten ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Based in ... organization focused on delivering exemplary solutions to the income ... ancillary benefits. In an effort to extend its reach ... and asset protection, Secura Consultants has brought aboard financial ... , “I am a big believer in specialization. When ...
(Date:11/28/2014)... 28, 2014 Top10inaction.com, a popular product ... Best Styling Tools For Hair in 2014 at ... such as T3 Featherweight 2 Hair Dryer, ghd Eclipse ... listed. , With the significant increase of awareness on ... but also home-used hair styling tools become necessities in ...
(Date:11/27/2014)... Recently, iFitDress.com, a reliable company of women’s special occasion ... of black cocktail dresses . The new models ... models are priced under $50. All customers who purchase ... a low shipping fee before Dec. 30, 2014. , ... The business has promised to offer only high quality ...
(Date:11/27/2014)... This is a professional and in-depth ... industry with a focus on the Chinese market. The ... the Bronchoscopes manufacturers and is a valuable source of ... the industry. , Firstly, the report provides a basic ... manufacturing technology. Then, the report explores the international and ...
Breaking Medicine News(10 mins):Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 3Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 4Health News:Matt Lee, CLU, ChFC Joins Secura Consultants as New Brokerage Consultant 2Health News:T3 Featherweight 2 Hair Dryer Is Named As Best Hair Styling Tool 2Health News:Beautiful Black Cocktail Dresses Offered by Top Dress Supplier iFitDress.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3
... ... month offers a potential boon to the diagnostic lab industry in the form of new ... said lab industry expert Dennis Weissman at a Slone Partners teleconference on the new law ... Miami, FL ...
... ... can now benefit from having critical documents e-Notarized by David Walsh, Solicitor and Notary ... Portsmouth, ... the longest established Certification Authorities (CA) and specialists in digital certificate security, has today ...
... ... Myeexpert in partnership with Strategic Insight Publishing, took a step further with ... Healthy Living and Relationships. , ... (PRWEB) May 4, 2010 -- Quoting verses from the book, the Founder and CEO of ...
... ... LLP have again been named as Ohio Super Lawyers®. This honor, by the much respected ... accomplished medical malpractice attorneys. Congratulations! , ... Cleveland, OH (PRWEB) May 4, 2010 -- Spangenberg lawyers were again honored this ...
... ... shown that the NeverWet Clear-n-Clean Plunger repels contaminated toilet water, keeping this bathroom plunger ... ... of consumer products created with their patent-pending Nanotech coating that repels water. Its first ...
... As ... seekers to explore the water sector to discover careers that are both central to public ... ... Week continues, the American Water Works Association (AWWA) is urging students and job ...
Cached Medicine News:Health News:Lab Industry Likely to Benefit from Expanded Preventive Testing Under New Health Care Law 2Health News:Lab Industry Likely to Benefit from Expanded Preventive Testing Under New Health Care Law 3Health News:GlobalSign Announces First Successful E-Notarization in Ireland 2Health News:GlobalSign Announces First Successful E-Notarization in Ireland 3Health News:GlobalSign Announces First Successful E-Notarization in Ireland 4Health News:“You Are Very Pretty”, Says Myeexpert As It Releases A Book, Poetic Expressions, Dedicated To The Beauty of Women. 2Health News:Cleveland Attorneys Recognized as Ohio Super Lawyers on 2010 List 2Health News:Cleveland Attorneys Recognized as Ohio Super Lawyers on 2010 List 3Health News:Ross Nanotechnology Corporation Introduces the NeverWet™ Coating on its First Consumer Product – The Clear-n-Clean Plunger 2Health News:During Drinking Water Week 2010, Water Sector Urges Students, Job Seekers to Work for Water 2
Transcranial vascular DWL doppler....
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
Medicine Products: